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Abstract Mesothelial cells are susceptible to asbestos
fiber-induced cytotoxicity and on longer time scales to
transformation; the resulting mesothelioma is a highly
aggressive neoplasm that is considered as incurable at
the present time Zucali et al. (Cancer Treatment
Reviews 37:543–558, 2011). Only few murine cell cul-
ture models of immortalized mesothelial cells and meso-
thelioma cell lines exist to date. We generated SV40-
immortalized cell lines derived from wild-type (WT)
and neurofibromatosis 2 (merlin) heterozygote (Nf2+/−)
mice, both on a commonly used genetic background,
C57Bl/6J. All immortalized mesothelial clones consis-
tently grow in DMEM supplemented with fetal bovine
serum. Cells can be passaged for more than 40 times
without any signs of morphological changes or a de-
crease in proliferation rate. The tumor suppressor gene
NF2 is one of the most frequently mutated genes in hu-
man mesothelioma, but its detailed function is still un-
known. Thus, these genotypically distinct cell lines likely
relevant for malignant mesothelioma formation are ex-
pected to serve as useful in vitro models, in particular
to compare with in vivo studies in mice of the same
genotype. Furthermore, we generated a novel murine me-
sothelioma cell line RN5 originating from an Nf2+/−
mouse subjected to repeated crocidolite exposure. RN5
cells are highly tumorigenic.
Keywords Mesothelioma . Asbestos .Mouse cell lines . Cell
models . Immortalized . SV40
Introduction
Malignant mesothelioma (MM) is an aggressive form of
cancer with an average survival time of about 1 yr; up to
date, conventional therapies have proven to be rather un-
successful (Rascoe et al. 2012). Tumors are derived from
transformed mesothelial cells, a cell type that is covering
the internal cavities of the pericardium, peritoneum, and
the pleura. The mesothelium is a cell monolayer consisting
of flat cells, forming the barrier between the tunica muco-
sae parietalis and visceralis. Pleural MM is linked in up to
80% of the cases with asbestos exposure (Carbone et al.
2011). Besides exposure to asbestos fibers leading to MM
formation, other etiologies including genetic disposition
and, rarely, ionizing radiation were found associated to
MM (Carbone et al. 2011; Chirieac et al. 2013). In addi-
tion, SV40 oncoproteins [large T and small t antigen (TAg
and tag, respectively)] together with asbestos fibers were
demonstrated to be co-carcinogenic (Bocchetta et al. 2000;
Kroczynska et al. 2006). Animal models to study MM
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were long hampered due to the slow time-course between
asbestos exposure and MM formation, a period that ranges
from 20 to 40 yr in humans (Bianchi et al. 1997).
Exposure of wild-type (WT) mice to asbestos fibers, even
at high doses, results in the formation of MM only in a
small fraction of animals (<33%) (Altomare 2005).
Mutations in the NF2 gene have been found in about
40% of human mesothelioma (Bianchi et al. 1995;
Sekido et al. 1995; Deguen et al. 1998), and the influence
of Nf2 heterozygosity has been investigated in mice; Nf2
heterozygosity was shown to result in MM at high fre-
quency (85%) within 1 yr after repetitive asbestos expo-
sure (Altomare 2005). In another transgenic mouse model,
SV40 TAg expression driven by the mesothelin promoter
leads to asbestos-induced MM in <1 yr (Robinson et al.
2006). However, for many aspects of MM research, in
particular for the investigation of the early steps of
mesotheliomagenesis, cell lines are of utmost importance,
providing relatively inexpensive model systems with high
throughput capacities and reducing the need for animal
experiments. For the investigation of the early steps of
MM formation, immortalized cell lines derived from pri-
mary mesothelial cells are the tools of choice. The most
used immortalized human mesothelial cell lines are MeT-
5A immortalized with SV40 (Ke et al. 1989) and LP9
cells immortalized with TERT1, the catalytic component
of te lomerase (Connel l and Rheinwald 1983) .
Immortalized mesothelioma and mesothelial cells of mouse
origin include cells isolated from the ascites of asbestos-
exposed wild-type C57Bl/6J or BALB/c mice [40, 40L,
AE17, AK7 (Cordier Kellerman et al. 2003), and AB12
(Davis et al. 1992)], SV40 TAg transgenic mice
[MexTAg, line names TGM299h, TGM304i, TGM270i,
and TGM266i (Robinson et al. 2006), conditional
Nf2−/− mice (Jongsma et al. 2008)], and spontaneously
immortalized cells obtained after prolonged culturing of
primary mouse mesothelial cells (Sherwood et al. 2008).
Here, we established SV40-immortalized mesothelial cells
of WT mice and immortalized cells derived from (Nf2+/−)
mice; all lines stem from mesothelial cells isolated from
mice with C57Bl/6J background. We expect the latter cell
lines to serve as valuable models to investigate in further
detail the role of Nf2 (merlin) in vitro and to complement
in vivo studies carried out in Nf2+/− mice. Immortalized
mesothelial cell lines were not tumorigenic, but showed
anchorage-independent growth in the spheroid formation
assay, thus allowing to use them as 3D cell culture
models (Smalley et al. 2006). Since the role of SV40
in MM is still controversially discussed in the mesothe-
lioma field (Carbone et al. 2003), the different immor-
talized mesothelial cell lines also provide a model to
investigate the effect of inactivating p53 in different
genotypes (WT, Nf2+/−). Finally, a novel murine mouse
mesothelioma cell line RN5 was generated from a tumor
that had developed in a crocidolite-exposed Nf2+/−
mouse; this line shows high tumorigenicity in vivo
and persistent growth in vitro.
Materials and Methods
Isolation of mouse primary mesothelial cells and mesothelio-
ma cells from a NF2+/− mouse. Mesothelial cells were iso-
lated from 4 to 6 months old WT and Nf2+/− mice, all on a
C57Bl/6J background using a previously described protocol
(Bot et al. 2003). Briefly, mice were killed and the peritoneal
cavities were exposed by incision and removal of the fur. The
peritoneal cavities were washed with injecting approximately
50 ml of phosphate-buffered saline (PBS) (Sigma, St. Louis)
via a syringe equipped with a 25G×5/8″ needle (BD
microlance 3, Becton Dickinson AG, Allschwil ,
Switzerland) using a peristaltic pump and a second needle
(23G, 0.6×25 mm) to allow exit of the PBS solution.
Perfusion was maintained until the exiting PBS solution was
clear, i.e., devoid of mobile and poorly attached cells.
Residual PBS was aspired with a syringe, and the peritoneal
cavity was filled with 5 ml of 0.25% Trypsin/EDTA solution
(Gibco, Basel, Switzerland). The body temperature of mouse
corpses was maintained at around 37°C for 5 min via an in-
frared heating lamp. The suspension containing the de-
tached cells was collected with a syringe; cells were
centrifuged for 10 min at 300×g. Cells mostly compris-
ing primary mesothelial cells were grown in modified
Connell’s medium composed of Dulbecco’s modified
Eagle’s medium (DMEM)/F12+GlutaMax (Gibco), 15%
fetal calf serum (FCS), 0.4 μg/ml hydrocortisone,
10 ng/ml epidermal growth factor, 1% ITS (insulin,
transferrin, selenium), 1 mM sodium pyruvate, 0.1 mM
beta-mercaptoethanol, 1% non-essential amino acids, 1%
penicillin–streptomycin, and 2% Mycokill (PAA)
(Connell and Rheinwald 1983). The Nf2 alleles (WT
or mutated) were genotyped using the common forward
primer (NF2_FW 5 ′-GGGGCTTCGGGAAACCTG
G-3′), and either NF2_RV WT (5′-GTCTGGGAAGTC
TGTGGAGG-3) or NF2_RV mutant (5′-CTATCAGG
ACATAGCGTTGG-3′) primers. The cell line RN5 was
isolated from an Nf2+/− mouse that was repeatedly
injected with crocidolite starting at 8 wk of age (7×
400 μg). Briefly, a clearly discernible tumor localized
on the liver was dissected from the mouse 21 wk after
the first injection. The tissue was incubated in a 0.25%
Trypsin/EDTA solution for 10 min; tumor cells were
dissociated by mild trituration and cultured in DMEM,
10% feta l bovine serum (FBS, Gibco , Base l ,
Switzerland), and 1% PS (100 U/mL penicillin and
100 μg/mL streptomycin).
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Cell culture and growth curves. Primary mesothelial cells
from the two genotypes (WT and Nf2+/−) were immortalized
by transduction with SV40 small and large T antigen.
Transduction was performed using lentivirus that were pro-
duced as previously described (Blum and Schwaller 2013).
The transfer plasmid pCMV/TO SV40 was obtained from
Addgene (# 22298). Primary cells were seeded at a density
of 10,000 cells/cm2; 24 h post-seeding cells were transfected
with lentivirus at an MOI of 5. Proliferation was monitored
using the Incucyte Live Cell Imaging System (Essen
Bioscience, Michigan). After passaging, cells were seeded at
a very low density (1–2 cells/cm2) in 10-cm Petri dishes.
Individual and well-delimited clones were picked and
transferred into 96-well plates and frozen at passages 7–
10 following standard protocols. 3-(4,5-Dimethylthiazol-
2yl)-2,5-diphenyltetrazolium bromide (MTT) assay was
performed as previously described (Blum and Schwaller
2013).
Western blot assay for mesothelin, SV40 large T-antigen,
and β-actin. Cells were grown in 75-cm2 cell culture flasks
(TPP, Trasadingen, Switzerland) until they reached nearly
100% confluence. Subsequently, cells were trypsinized and
pelleted (500×g, 3 min), then washed three times with CMF-
PBS. Proteins were extracted with RIPA buffer [50 mM Tris,
150 mM NaCl, 0.1% sodium dodecyl sulfate (SDS), 0.5%
sodium deoxycholate, 1% Triton X-100, pH 7.4], incubated
for 30 min on ice, and centrifuged 30 min at 17,000×g at 4°C,
and the supernatant was collected. The DC assay (BioRad)
was performed to quantify the proteins following the manu-
facturer’s protocol. Protein samples were separated on a 10%
polyacrylamide SDS gel and transferred onto nitrocellulose
membranes. Membranes were checked with Ponceau S stain-
ing for equal loading. Membranes were blocked with 5%milk
PBS for 1 h at room temperature and incubated overnight at
4°C with antibodies recognizing mesothelin (dilution 1:2,000;
Santa Cruz Biotechnology, Santa Cruz, CA, clone B-3), SV40
large T-antigen (1:2000; Santa Cruz Biotechnology, Pab101),
and β-actin (1:20,000; Sigma-Aldrich, clone ac-74).
Secondary biotinylated antibodies were used at a dilu-
tion of 1:20,000, and the ABC system (Vectastain,
Vector Laboratories, Burlingame, CA) was applied.
The HRP substrate (Millipore, Luminata Forte) was in-
cubated for 3 min on the membrane and analyzed on a
Western blot reader (FluorChem E System, Bucher
Biotec, Basel, Switzerland).
Soft agar assay. The procedure of the soft agar assay was
adapted from a previously described protocol (Provost et al.
2012). Shortly, 0.5% of base agar was prepared bymelting 1%
of agar (LuBioScience, Lucerne, Switzerland) in a microwave
oven and adding of prewarmed (40°C) 2× RPMI completed
with 20% FCS and antibiotics (penicillin-streptomycin) and
allowed to equilibrate to 37°C. Equal volumes of the solutions
were mixed to give final concentrations of 0.5% agar, 1×
RPMI, and 10% FCS. One milliliter was added per well in
six-well plates and set aside to solidify. Top agar was prepared
by melting 0.7% agarose (PeqLab, Erlangen, Germany) in a
microwave oven and cooled down to 40°C and then supple-
mented with an equal volume of 2× RPMI with 20% FCS also
at approximately 40°C. Cells (5000) in a volume of
1 ml of 0.35% agarose in 1× RPMI+10% FCS was
added to the solidified agar. Plates were incubated for
17 d in a humidified incubator at 37°C with 5% CO2.
Twice per week, the plates were supplied with 0.5 ml of
cell culture medium.
Subcutaneous xenograft model. WT C57Bl/6J mice (6–8 wk
old; n=3–5 animals depending on the group) were inoculated
s.c. with 4×105 cells by injection of the cell suspension (50 μl
in PBS containing 20% matrigel) into the right dorsal flank.
Cells included immortalized mesothelial cells (iMeso-WT1
and iMeso-NF3), the MM cell line RN5, and the previously
described murineMM cell line AK7 (Cordier Kellerman et al.
2003), the latter also on a C57Bl/6J background. Tumors were
measured with a caliper weekly as soon as palpable; the vol-
ume was calculated using the formula a×b2×0.5, where a is
the large and b the small diameter of an ellipse. For the
Figure 1. Morphology (a) and growth characteristics (b) of primary
mesothelial cells isolated from WT and Nf2+/− mice, both grown in
Connell’s medium. (a) Mesothelial cells from both genotypes show the
typical Bcobblestone-like^ morphology. (b) Nf2+/− cells show slightly
increased proliferation compared to WT cells; representative growth
curves for n>3 experiments are shown.
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immunohistochemistry, deparaffinized sections were subject-
ed to antigen retrieval using sodium citrate, pH 6, then were
processed as previously described (Frei et al. 2011). Primary
antibodies used were anti-wide spectrum cytokeratin and anti-
vimentin (Abcam Ab9377, 1:100 and Ab92547, 1:500,
respectively).
Immunofluorescence experiments. Cells were seeded on glass
coverslips and incubated with the appropriate cell culture me-
dium until a confluence of 70–90% was reached. Then, the
cells were fixed with 4% PFA, permeabilized with 1% Triton
X-100, and blocked with TBS solution containing donkey
serum (10%). Cells were incubated overnight at 4°C with
the primary antibodies at the indicated dilutions: mouse mono-
clonal anti-pan-cytokeratin, clone Lu-5 (BMA Biomedicals,
Augst, Switzerland, T-1302; 1:500), or rabbit polyclonal anti-
desmin (Sigma D8281; 1:500). After washing, the cell-
containing coverslips were incubated with secondary antibod-
ies for 1 h with either DyLight488-conjugated donkey anti-
mouse IgG (Jackson Immunoresearch Laboratories, West
Grove, PA; 1:1,000) or Cy3-conjugated donkey anti-rabbit
IgG (Jackson Immunoresearch Laboratories; 1:1,000). The
cells were counterstained with DAPI (Molecular Probes,
Eugene, OR; 5 μg/ml) and mounted with Hydromount solu-
tion (National Diagnostics, Atlanta, GA). Images were ac-
quired with a LEICA fluorescent microscope DM6000B
(Wetzlar, Germany) equipped with a Hamamatsu camera
C4742-95 (Bridgewater, NJ).
Results
Immortalized primary mouse mesothelial persistently grow
in vitro. Primary mesothelial cells isolated from WT and
Nf2+/− mice were initially grown in Connell’s medium, a
Figure 2. Immortalized mesothelial cell morphology and cell growth in
DMEM+10% FBS. (a) Brightfield images were taken with the Incucyte
Live Cell Imaging system (FLR 10×) and show immortalized mesothelial
cell clones derived fromWTand Nf2+/−mice. The typical Bcobblestone-
like^morphology is conserved; all clones show a higher proliferation rate
than their nonimmortalized primary counterparts (scale bar: 100 μm). (b)
Representative Incucyte growth curves of WT and Nf2+/− clones. (c)
MTT signals obtained at 144 h postseeding using all cells and cell lines
as in Fig. 1 and 2a. (d) MTT data grouped for three clones each of the
genotypesWTand Nf2+/− in comparison to the primary mesothelial cells
(*p<0.05; ***p<0.0005).
Figure 3. Western blot for SV40 large T antigen and mesothelin in WT
and Nf2+/− cells in comparison of the primary immortalized clones from
WT and Nf2+/− mesothelial cells. (a) Western blot signals from a
representative experiment. The Western blot signals for β-actin were used
for the normalization of the mesothelin expression levels. (b) Quantitative
analysis of a representative Western blot (n=3 samples per genotype,
p<0.05 grouped primary cells vs. grouped immortalized cell lines).
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medium previously shown to be optimal for mesothelial cell
growth (Connell and Rheinwald 1983). Growth of cells from
both genotypes was faster then in the medium used for the
further experiments, i.e., in DMEM supplemented with 10%
FBS (data not shown). Primary mesothelial cells fromWTand
Nf2+/− mice grown in DMEM showed the typical
cobblestone-like morphology similar as, e.g., the human me-
sothelioma cell line ZL55 consisting of cells with an epitheli-
oid morphology used in previous studies (Blum and Schwaller
2013) (Fig. 1a). As shown before for WT primary mouse
mesothelial cells (Robinson et al. 2006), mesothelial cells
from the two genotypes grew in vitro for approximately 8–
10 passages, followed by a prolonged period of quiescence
lasting for up to several weeks before finally dying.
Of note, primary mesothelial cells (initial density, 1500
cells/cm2) from Nf2+/− mice showed slightly enhanced pro-
liferation compared to the cell lines generated from WT mice
(Fig. 1b). From the initial batch of immortalized cells, by
limited dilution, clones derived from three colonies for each
genotype, likely originating from a single cell, thus
representing single clones, were isolated, expanded, and
stored for further usage. Unlike the primary mesothelial cells,
SV40-immortalized mesothelial cell clones (iMeso-WT,
iMeso-Nf2) grew rapidly in DMEM supplemented with 10%
FBS (Fig. 2). Cells from both genotypes showed persistent
cell proliferation even under low serum conditions (2%) and
all survived for prolonged periods of time (>120 h) under very
low serum conditions (0.5%), however without signs of pro-
liferation evidenced by lack of mitotic cells (data not shown).
All cultured mesothelial cells showed the typical cobblestone-
like morphology like primary mesothelial cells from WT and
Nf2+/− (Fig. 2a). All clones irrespective of genotype main-
tained their typical pavement-like morphology, and moreover,
immortalized cell lines of both genotypes showed an in-
creased cell proliferation rate when compared to the initial
primary mesothelial cells (Fig. 2b) evidenced from real-time
growth curves, as well as from the results of an independent
proliferation assay, the MTT assay, carried out 144 h post-
plating (Fig. 2c). Of note within one genotype (WT and
Nf2+/−), growth rates of the various clones were considerably
different, e.g.,WTclones 1, 2, and 3 reached the plateau (close
to 100% confluence) within 100, 80, and ≈140 h, respectively
(Fig. 2b); similar proliferation rates were also observed for
Nf2+/− clones. This was also confirmed using the MTT assay
(Fig. 2c), when clones were grouped according to their geno-
type. No significant differences in growth rates were evident
between the group of WT and NF2+/− clones (Fig. 2d). All
SV40-immortalized mesothelial cell lines (clones) were cul-
tured for more than 40 passages without showing any signs of
Figure 4. Colony formation assay. (a) Primary WT mesothelial cells
were able to form colonies in plates with soft agar, as well as the
human MM-derived cell line MSTO-211H (b) used as a positive
control (derived from a biphasic mesothelioma). Selected colonies
typically representing the morphological appearance of immortalized
cells iMeso-WT1 (c), and iMeso-NF3 (d) are shown. Scale bar: 250 μm.
Figure 5. Morphology and growth of themurinemesothelioma cell lines
RN5, AK7, and AB12 in vitro. (a) Epithelioid morphology of RN5 and
AK7 compared to biphasic or mixed type morphology of AB12 cells.
Cell size, morphology, and growth characteristics (b) are strikingly
similar for RN5 and AK7 cells. (c) Immunofluorescene images of RN5
cells show a rather homogeneous staining for desmin (red). Pan-
cytokeratin staining (green) shows a typical mosaic pattern; cell nuclei
were labeled with DAPI (blue). (d) Western blot analysis (30 μg total
protein/lane) showing the expression of mesothelin in the three murine
mesothelioma cell lines RN5, AK7, and AB12.
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a decreased growth and/or changes in cell morphology. A
stock was produced at passage number 7–10 and frozen for
long-term storage.
Characterization of primary and immortalized mesothelial
cells. As expected, primary mesothelial cells of either geno-
type (WT, Nf2+/−), as well as the murine macrophage cell line
RAW264.7 (Raschke et al. 1978), did not express TAg evi-
denced by Western blotting (Fig. 3a). Strong TAg expression
was observed in all primary mesothelial cell clones transfected
with the lentivirus coding for TAg/tag (Fig. 3). All cells (pri-
mary, immortalized) of mesothelial origin were clearly posi-
tive for mesothelin, a mesothelial cell-specific marker. The
single positive band on the Western blots had a relative
molecular mass (Mr) of 69 kDa corresponding to the
mesothelin precursor protein. Western blot quantification
revealed decreased mesothelin levels in immortalized
cell clones from both genotypes compared to primary
cells WT mice (Fig. 3b). Immunohistochemical analysis
showed homogeneous positive staining for desmin and
mosaic-like expression for Pan-cytokeratin in all exam-
ined cell lines including the primary mesothelial cul-
tures, the immortalized cells, and the tumor-derived
RN5 cells. A typical example for RN5 cells is shown
in Fig. 5c.
Primary mesothelial cells and SV40-immortalized mesothelial
cells form colonies in the soft agar assay. Since immortalized
mesothelial cell clones of both genotypes (WT, Nf2+/−) also
proliferated in low-serum (2%) conditions, a feature often ob-
served in transformed cells, we investigated another aspect
related to cell transformation, i.e., their ability to form
anchorage-independent colonies in a semisolid medium.
Cells from the various clones grew in soft agar, and images
were taken after 17 d (Fig. 4). We then also tested primary
mesothelial cells from WT mice; they were also able to form
colonies of ≥250 μm diameter after 17 d of growth in
anchorage-independent conditions (Fig. 4). These findings
are in line with results on human primary mesothelial cells,
where colony formation in semisolid medium has been report-
ed before (La Rocca and Rheinwald 1985). Thus, anchorage-
independent growth of primary mesothelial cells appears not
to be restricted to cells of human origin; moreover, the soft
agar assay does not allow to distinguish primary from immor-
talized or even transformed (RN5) cells. As a positive control,
the human MM cell line MSTO-211H was used. The
sole purpose of these experiments was to test whether
or not murine mesothelial cells (primary, immortalized)
have the capability of growing in soft agar in an
anchorage-independent way. No attempt was made to
correlate the mesothelial cell’s nature (primary vs. im-
mortalized vs. transformed, from WT vs. transgenic
mice) with the size of the colonies.
Morphological and growth characteristics of the novel RN5
cell line compared to AK7 and AB12mouse mesothelioma cell
lines. We isolated a primary tumor obtained after repeated
injection of asbestos fibers in the peritoneum of an Nf2+/−
mouse. At the age of 29 wk, many tumors covered the spleen
and the liver of this mouse. From a well-delimited piece of
tumor tissue, the tumor cells were isolated by trypsinization of
the tumor tissue followed by plating in DMEM. These cells,
named RN5, have a similar morphology like AK7 cells
in vitro, i.e., both cell lines show an epithelioid morphology,
nearly as cobblestone-like as primary mesothelial cells (com-
pare Fig. 5a and Fig. 1a). AB12 cells show sarcomatoid mor-
phology in most cells and some epithelioid cells hinting to-
wards a biphasic type. All three cell lines show fast
Figure 6. RN5 subcutaneous xenograft. (a) Xenograft growth
monitored weekly 24 d after inoculation (n=4 mice). (b) Histological
sections of the xenograft stained by hematoxylin and eosin (left) and
Goldner (right) showing the skin (s), the subcutaneous fat tissue ( f ),
and muscle (m). Scale bar: 1 mm. (c) Magnification emphasizing tumor
tissue (t) from the Goldner colored section. Scale bar: 250 μm.
Immunohistochemical analysis showed expression of vimentin (d) with
strong coexpression of pan-cytokeratin (e) in part of the tumor cell
population.
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proliferation and similar growth characteristics as evidenced
by real-time imaging experiments (Fig. 5b).
RN5 cells form tumors in the subcutaneous xenograft
model. Primary mesothelial cells from WT mice, immortal-
ized cells iMeso-WT1, iMeso-NF3, and mesothelioma cells
from the lines AK7 and RN5, all derived from a C57Bl/6J
background, were injected (4×105 cells) subcutaneously into
the right flank of C57Bl/6J mice. Tumor formation was ob-
served in all four mice injected with RN5 cells (Fig. 6a). No
macroscopically evident (palpable) tumors were observed in
mice injected with primary mesothelial cells of WT origin or
with immortalized cells (iMeso). No tumors developed after
injection of the selected number of AK7 cells; a significantly
higher number (>2×106 cells) has been reported to be re-
quired in order to induce macroscopic tumors in this experi-
mental model (Cordier Kellerman et al. 2003). The tumor
tissue originating from RN5 cells isolated 59 d after injection
was white in color and rather solid at palpation. On histological
sections subjected to a Goldner staining, a fibrous stroma was
evident (Fig. 6c). Histological examination of tumors (Fig. 6b)
derived from RN5 cells isolated 59 d after injection revealed a
proliferation of atypical cells with a sarcomatoid morphology.
The tumor was mainly confined to the subcutaneous tissue with
infiltration of small clusters as well as individual cells into the
dermis. Immunohistochemically, the tumor cells were positive
for vimentin with strong coexpression of pancytokeratin in part
of the cell population (Fig. 6d, e). No expression was seen
for WT1 and calretinin (data not shown). The morphology
combined with staining for vimentin and pancytokeratin is
consistent with a sarcomatoid mesothelioma.
Discussion
Cell culture systems in vitro represent helpful models to in-
vestigate tumor formation and, together with murine cancer
models in vivo, have become a fundamental tool in Life
Sciences (Balmain 2002). We generated simultaneously and
on the same C57Bl/6J genetic background SV40-
immortalized murine peritoneal mesothelial cell clones from
two different genotypes: WT and Nf2+/−. This strategy offers
several advantages in studies aimed to characterize, e.g.,
nanomaterial toxicity (asbestos, novel nanomaterials). The
most obvious is that it allows characterizing the influence of
Nf2 (merlin) without concerns about the influence of a genetic
drift observed in inbred strains with mixed background or in
C57BL/6 substrains (Zurita et al. 2011). Our murine cell lines
derived from Nf2 heterozygous mice provide a model system
to investigate Nf2 (merlin) function and to possibly investi-
gate the mechanisms leading to the inactivation of the
nonmutated allele. Indeed, although Nf2-deficient murine cell
lines are available (Jongsma et al. 2008), they are, in addition,
also deficient for cyclin-dependent kinase inhibitor 2A
(Cdkn2a) and, moreover, are on a mixed genetic background.
Mesothelial lines immortalized with SV40 T antigens have
allowed highlighting the importance of p53 in maintaining
genomic stability (Levresse et al. 2000; Pietruska and Kane
2007). We confirmed that SV40 T antigen expression, al-
though accelerating the rate of the cell cycle, consistent with
previous data (reviewed in An et al. 2012), is not sufficient to
transform mesothelial cells (Cleaver et al. 2014). Therefore,
they may constitute a suitable model to investigate early steps
of mesothelial transformation, however also taking into con-
sideration the limitations of such a model.
The establishment of the novel mouse mesothelioma cell
line RN5 originated from a heterozygote Nf2+/− mouse on a
C57Bl/6J background is expected to be useful also for in vivo
investigations on (1) the modulation of tumor growth by de-
creased merlin levels (possibly linked to loss of heterozygosi-
ty), (2) the role of the immune system in asbestos-mediated
mesothelioma development, and (3) the role of other stromal
components in tumorigenesis. Tumorigenicity could be inves-
tigated in WT vs. the large variety of C57Bl/6J derived-mice
deficient in stromal components. Moreover, RN5 is the first cell
line from C57Bl/6J mice that is uniquely heterozygous for Nf2.
In conclusion, we have established new immortalized
mouse mesothelial cell lines that provide model systems to
study, e.g., mechanisms implicated in mesothelial transforma-
tion or to test for nanomaterial toxicity. We expect that these
in vitro models will also help to reduce animal experimenta-
tion. The cell line RN5 was demonstrated to be fast and per-
sistently growing in vitro and to be highly tumorigenic in
syngeneic C57Bl/6J mice. These tumor cell-exposed mice
are expected to retain a functional immune response. We fore-
see that this in vivo model will allow for testing putative
therapeutic options against malignant mesothelioma.
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